Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer
- Autores
- Menendez, Javier A.; Peirce, Susan K.; Papadimitropoulou, Adriana; Cuyàs, Elisabet; Steen, Travis Vander; Verdura, Sara; Vellón, Luciano; Chen, Wen Y.; Lupu, Ruth
- Año de publicación
- 2020
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Progesterone receptor (PR) isoforms can drive unique phenotypes in luminal breast cancer (BC). Here, we hypothesized that PR-B and PR-A isoforms differentially modify the cross-talk between prolactin and fatty acid synthase (FASN) in BC. We profiled the responsiveness of the FASN gene promoter to prolactin in T47Dco BC cells constitutively expressing PR-A and PR-B, in the PR-null variant T47D-Y cell line, and in PR-null T47D-Y cells engineered to stably re-express PR-A (T47D-YA) or PR-B (T47D-YB). The capacity of prolactin to up-regulate FASN gene promoter activity in T47Dco cells was lost in T47D-Y and TD47-YA cells. Constitutively up-regulated FASN gene expression in T47-YB cells and its further stimulation by prolactin were both suppressed by the prolactin receptor antagonist hPRL-G129R. The ability of the FASN inhibitor C75 to decrease prolactin secretion was more conspicuous in T47-YB cells. In T47D-Y cells, which secreted notably less prolactin and downregulated prolactin receptor expression relative to T47Dco cells, FASN blockade resulted in an augmented secretion of prolactin and up-regulation of prolactin receptor expression. Our data reveal unforeseen PR-B isoform-specific regulatory actions in the cross-talk between prolactin and FASN signaling in BC. These findings might provide new PR-B/FASN-centered predictive and therapeutic modalities in luminal intrinsic BC subtypes
Fil: Menendez, Javier A.. Institut Català d'Oncologia; España. Institut d’Investigació Biomèdica de Girona; España
Fil: Peirce, Susan K.. Clemson University. Pearce Center Professional Communication; Estados Unidos
Fil: Papadimitropoulou, Adriana. Biomedical Research Foundation Academy of Athens; Grecia
Fil: Cuyàs, Elisabet. Institut Català d'Oncologia; España. Institut d’Investigació Biomèdica de Girona; España
Fil: Steen, Travis Vander. Mayo Foundation for Medical Education and Research. Mayo Clinic; Estados Unidos
Fil: Verdura, Sara. Institut Català d'Oncologia; España. Institut d’Investigació Biomèdica de Girona; España
Fil: Vellón, Luciano. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina
Fil: Chen, Wen Y.. Clemson University; Estados Unidos
Fil: Lupu, Ruth. Mayo Foundation for Medical Education and Research. Mayo Clinic; Estados Unidos. Clemson University; Estados Unidos. Mayo Clinic Cancer Center; Estados Unidos - Materia
-
ENDOCRINE THERAPY
G129R
LUMINAL BREAST CANCER
PROLACTIN RECEPTOR - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/131957
Ver los metadatos del registro completo
id |
CONICETDig_9a914afad1938efd5355f172c6dcc642 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/131957 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancerMenendez, Javier A.Peirce, Susan K.Papadimitropoulou, AdrianaCuyàs, ElisabetSteen, Travis VanderVerdura, SaraVellón, LucianoChen, Wen Y.Lupu, RuthENDOCRINE THERAPYG129RLUMINAL BREAST CANCERPROLACTIN RECEPTORhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Progesterone receptor (PR) isoforms can drive unique phenotypes in luminal breast cancer (BC). Here, we hypothesized that PR-B and PR-A isoforms differentially modify the cross-talk between prolactin and fatty acid synthase (FASN) in BC. We profiled the responsiveness of the FASN gene promoter to prolactin in T47Dco BC cells constitutively expressing PR-A and PR-B, in the PR-null variant T47D-Y cell line, and in PR-null T47D-Y cells engineered to stably re-express PR-A (T47D-YA) or PR-B (T47D-YB). The capacity of prolactin to up-regulate FASN gene promoter activity in T47Dco cells was lost in T47D-Y and TD47-YA cells. Constitutively up-regulated FASN gene expression in T47-YB cells and its further stimulation by prolactin were both suppressed by the prolactin receptor antagonist hPRL-G129R. The ability of the FASN inhibitor C75 to decrease prolactin secretion was more conspicuous in T47-YB cells. In T47D-Y cells, which secreted notably less prolactin and downregulated prolactin receptor expression relative to T47Dco cells, FASN blockade resulted in an augmented secretion of prolactin and up-regulation of prolactin receptor expression. Our data reveal unforeseen PR-B isoform-specific regulatory actions in the cross-talk between prolactin and FASN signaling in BC. These findings might provide new PR-B/FASN-centered predictive and therapeutic modalities in luminal intrinsic BC subtypesFil: Menendez, Javier A.. Institut Català d'Oncologia; España. Institut d’Investigació Biomèdica de Girona; EspañaFil: Peirce, Susan K.. Clemson University. Pearce Center Professional Communication; Estados UnidosFil: Papadimitropoulou, Adriana. Biomedical Research Foundation Academy of Athens; GreciaFil: Cuyàs, Elisabet. Institut Català d'Oncologia; España. Institut d’Investigació Biomèdica de Girona; EspañaFil: Steen, Travis Vander. Mayo Foundation for Medical Education and Research. Mayo Clinic; Estados UnidosFil: Verdura, Sara. Institut Català d'Oncologia; España. Institut d’Investigació Biomèdica de Girona; EspañaFil: Vellón, Luciano. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; ArgentinaFil: Chen, Wen Y.. Clemson University; Estados UnidosFil: Lupu, Ruth. Mayo Foundation for Medical Education and Research. Mayo Clinic; Estados Unidos. Clemson University; Estados Unidos. Mayo Clinic Cancer Center; Estados UnidosImpact Journals2020-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/131957Menendez, Javier A.; Peirce, Susan K.; Papadimitropoulou, Adriana; Cuyàs, Elisabet; Steen, Travis Vander; et al.; Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer; Impact Journals; Aging; 12; 24; 12-2020; 24671-246921945-4589CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.18632/aging.202289info:eu-repo/semantics/altIdentifier/url/https://www.aging-us.com/article/202289/textinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:33:38Zoai:ri.conicet.gov.ar:11336/131957instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:33:38.733CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer |
title |
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer |
spellingShingle |
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer Menendez, Javier A. ENDOCRINE THERAPY G129R LUMINAL BREAST CANCER PROLACTIN RECEPTOR |
title_short |
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer |
title_full |
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer |
title_fullStr |
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer |
title_full_unstemmed |
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer |
title_sort |
Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer |
dc.creator.none.fl_str_mv |
Menendez, Javier A. Peirce, Susan K. Papadimitropoulou, Adriana Cuyàs, Elisabet Steen, Travis Vander Verdura, Sara Vellón, Luciano Chen, Wen Y. Lupu, Ruth |
author |
Menendez, Javier A. |
author_facet |
Menendez, Javier A. Peirce, Susan K. Papadimitropoulou, Adriana Cuyàs, Elisabet Steen, Travis Vander Verdura, Sara Vellón, Luciano Chen, Wen Y. Lupu, Ruth |
author_role |
author |
author2 |
Peirce, Susan K. Papadimitropoulou, Adriana Cuyàs, Elisabet Steen, Travis Vander Verdura, Sara Vellón, Luciano Chen, Wen Y. Lupu, Ruth |
author2_role |
author author author author author author author author |
dc.subject.none.fl_str_mv |
ENDOCRINE THERAPY G129R LUMINAL BREAST CANCER PROLACTIN RECEPTOR |
topic |
ENDOCRINE THERAPY G129R LUMINAL BREAST CANCER PROLACTIN RECEPTOR |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Progesterone receptor (PR) isoforms can drive unique phenotypes in luminal breast cancer (BC). Here, we hypothesized that PR-B and PR-A isoforms differentially modify the cross-talk between prolactin and fatty acid synthase (FASN) in BC. We profiled the responsiveness of the FASN gene promoter to prolactin in T47Dco BC cells constitutively expressing PR-A and PR-B, in the PR-null variant T47D-Y cell line, and in PR-null T47D-Y cells engineered to stably re-express PR-A (T47D-YA) or PR-B (T47D-YB). The capacity of prolactin to up-regulate FASN gene promoter activity in T47Dco cells was lost in T47D-Y and TD47-YA cells. Constitutively up-regulated FASN gene expression in T47-YB cells and its further stimulation by prolactin were both suppressed by the prolactin receptor antagonist hPRL-G129R. The ability of the FASN inhibitor C75 to decrease prolactin secretion was more conspicuous in T47-YB cells. In T47D-Y cells, which secreted notably less prolactin and downregulated prolactin receptor expression relative to T47Dco cells, FASN blockade resulted in an augmented secretion of prolactin and up-regulation of prolactin receptor expression. Our data reveal unforeseen PR-B isoform-specific regulatory actions in the cross-talk between prolactin and FASN signaling in BC. These findings might provide new PR-B/FASN-centered predictive and therapeutic modalities in luminal intrinsic BC subtypes Fil: Menendez, Javier A.. Institut Català d'Oncologia; España. Institut d’Investigació Biomèdica de Girona; España Fil: Peirce, Susan K.. Clemson University. Pearce Center Professional Communication; Estados Unidos Fil: Papadimitropoulou, Adriana. Biomedical Research Foundation Academy of Athens; Grecia Fil: Cuyàs, Elisabet. Institut Català d'Oncologia; España. Institut d’Investigació Biomèdica de Girona; España Fil: Steen, Travis Vander. Mayo Foundation for Medical Education and Research. Mayo Clinic; Estados Unidos Fil: Verdura, Sara. Institut Català d'Oncologia; España. Institut d’Investigació Biomèdica de Girona; España Fil: Vellón, Luciano. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina Fil: Chen, Wen Y.. Clemson University; Estados Unidos Fil: Lupu, Ruth. Mayo Foundation for Medical Education and Research. Mayo Clinic; Estados Unidos. Clemson University; Estados Unidos. Mayo Clinic Cancer Center; Estados Unidos |
description |
Progesterone receptor (PR) isoforms can drive unique phenotypes in luminal breast cancer (BC). Here, we hypothesized that PR-B and PR-A isoforms differentially modify the cross-talk between prolactin and fatty acid synthase (FASN) in BC. We profiled the responsiveness of the FASN gene promoter to prolactin in T47Dco BC cells constitutively expressing PR-A and PR-B, in the PR-null variant T47D-Y cell line, and in PR-null T47D-Y cells engineered to stably re-express PR-A (T47D-YA) or PR-B (T47D-YB). The capacity of prolactin to up-regulate FASN gene promoter activity in T47Dco cells was lost in T47D-Y and TD47-YA cells. Constitutively up-regulated FASN gene expression in T47-YB cells and its further stimulation by prolactin were both suppressed by the prolactin receptor antagonist hPRL-G129R. The ability of the FASN inhibitor C75 to decrease prolactin secretion was more conspicuous in T47-YB cells. In T47D-Y cells, which secreted notably less prolactin and downregulated prolactin receptor expression relative to T47Dco cells, FASN blockade resulted in an augmented secretion of prolactin and up-regulation of prolactin receptor expression. Our data reveal unforeseen PR-B isoform-specific regulatory actions in the cross-talk between prolactin and FASN signaling in BC. These findings might provide new PR-B/FASN-centered predictive and therapeutic modalities in luminal intrinsic BC subtypes |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/131957 Menendez, Javier A.; Peirce, Susan K.; Papadimitropoulou, Adriana; Cuyàs, Elisabet; Steen, Travis Vander; et al.; Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer; Impact Journals; Aging; 12; 24; 12-2020; 24671-24692 1945-4589 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/131957 |
identifier_str_mv |
Menendez, Javier A.; Peirce, Susan K.; Papadimitropoulou, Adriana; Cuyàs, Elisabet; Steen, Travis Vander; et al.; Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer; Impact Journals; Aging; 12; 24; 12-2020; 24671-24692 1945-4589 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.18632/aging.202289 info:eu-repo/semantics/altIdentifier/url/https://www.aging-us.com/article/202289/text |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Impact Journals |
publisher.none.fl_str_mv |
Impact Journals |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614352069459968 |
score |
13.070432 |